GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Nevro Corp.
Shares of NWTN, a UAE-based premium electric vehicle manufacturer, are a highly speculative bet. Their price is driven not by financial performance, but by news of strategic partnerships and progress toward serial production, as the company seeks to carve out a niche in the luxury EV market.
Share prices of companies in the market segment - Therapeutic medical equipment
Nevro Corp. is a medical device company that has developed a spinal cord neurostimulation system for the treatment of chronic pain. We've classified it as a "Therapeutic Medical Device." The chart below shows how investors value companies offering alternatives to opioid therapy.
Broad Market Index - GURU.Markets
Nevro Corp. is a medical device company that has developed a spinal cord neurostimulation system for the treatment of chronic pain. We've classified it as a "Therapeutic Medical Device." The chart below shows how investors value companies offering alternatives to opioid therapy.
Change in the price of a company, segment, and market as a whole per day
NVRO - Daily change in the company's share price Nevro Corp.
Nevro Corp.'s daily price change reflects volatility in the medical device sector. The indicator demonstrates sensitivity to sales of its spinal cord stimulation systems for the treatment of chronic pain.
Daily change in the price of a set of shares in a market segment - Therapeutic medical equipment
Nevro Corp. has developed and markets a neurostimulation system for the treatment of chronic pain. The medical pain management equipment market is competitive and highly technological. The chart below shows the average volatility in this sector, allowing you to compare NVRO's performance with other innovative companies.
Daily change in the price of a broad market stock, index - GURU.Markets
Nevro produces implantable devices for the treatment of chronic pain. The medtech company's stock performance depends on the adoption of its technology in medical practice. Its history reflects the innovative medical sector's contribution to overall market volatility.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Nevro Corp.
Nevro Corp.'s year-over-year performance tells the story of its performance in the neurostimulation market for chronic pain. Its market cap change over the past 12 months reflects its struggle for market share with its flagship product, Senza®, as well as its success in expanding its indications, which is key to its long-term growth.
Annual dynamics of market capitalization of the market segment - Therapeutic medical equipment
Nevro Corp. is a medical device company that has developed innovative neurostimulation technology for the treatment of chronic pain. The chart shows how its competition for market share with giants like Medtronic and its efforts to expand its indications are impacting its performance.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Nevro, a company that produces spinal cord stimulation systems for the treatment of chronic pain, is a leader in its niche. Its year-over-year market capitalization reflects its commercial success and ability to defend its market share from competitors.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Nevro Corp.
Nevro is a manufacturer of spinal cord stimulation systems for the treatment of chronic pain. Its monthly performance reflects growing sales of its Senza system. Quarterly revenue reports and competition in the neuromodulation market are key.
Monthly dynamics of market capitalization of the market segment - Therapeutic medical equipment
Nevro Corp. has developed and markets an innovative neurostimulation system for the treatment of chronic pain. Their technology offers an alternative to traditional opioid analgesics. The graph below shows the overall dynamics in the therapeutic device sector, reflecting the high demand for effective and safe pain management methods.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Medical technology stocks can combine defensive demand with the volatility of growth stocks. The chart below shows the overall sentiment. What influences Nevro Corp. more: stable demand for its devices or the overall market appetite for risk?
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Nevro Corp.
Shares of Nevro, a manufacturer of spinal cord stimulation systems for pain relief, reflect the competition in this market on a weekly basis. Price movements reflect data confirming the benefits of their high-frequency therapy and the acceptance of their technology by physicians.
Weekly dynamics of market capitalization of the market segment - Therapeutic medical equipment
Nevro Corp. has developed an innovative spinal cord stimulation system for the treatment of chronic pain. This chart compares its weekly performance with the medical device sector and helps us understand how its unique technology is capturing market share from competitors and traditional treatment methods.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Nevro produces systems for treating chronic pain. Demand for its products is driven by medical needs. The chart below will help you determine whether Nevro shares are truly a "safe haven" asset, demonstrating stability amid market uncertainty.
Market capitalization of the company, segment and market as a whole
NVRO - Market capitalization of the company Nevro Corp.
Nevro's market capitalization chart tells the story of a company that developed an innovative spinal cord stimulation system for treating chronic pain. Its decline reflects slowing growth and increasing competition. Its dynamics reflect the market's assessment of its ability to protect its technology and find new growth drivers.
NVRO - Share of the company's market capitalization Nevro Corp. within the market segment - Therapeutic medical equipment
Nevro Corp. produces systems for treating chronic pain. The company's significant share of the market capitalization of its medical devices segment speaks to the commercial success of its technology. The chart demonstrates how innovation and competition influence its leadership position in this specialized market.
Market capitalization of the market segment - Therapeutic medical equipment
Nevro is a manufacturer of spinal cord stimulation systems for the treatment of chronic pain. The chart below shows the overall market capitalization of the medical devices sector. Its dynamics reflect competition and innovation in the field of neuromodulation, where Nevro is a key player.
Market capitalization of all companies included in a broad market index - GURU.Markets
Nevro Corp. has developed a neurostimulation system for the treatment of chronic pain. Its market cap reflects the enormous need for alternatives to opioid analgesics. Its growth on the overall chart demonstrates how medical technology can offer new solutions to one of the most debilitating health problems.
Book value capitalization of the company, segment and market as a whole
NVRO - Book value capitalization of the company Nevro Corp.
Nevro Corp.'s book value is its capital and production capacity for producing a unique spinal cord neurostimulation system for treating chronic pain. This is real, science-intensive capital for combating pain without opioids. How has this innovative medical technology asset evolved? The chart below reveals its complex history.
NVRO - Share of the company's book capitalization Nevro Corp. within the market segment - Therapeutic medical equipment
Nevro produces neurostimulation systems for the treatment of chronic pain. The chart shows the proportion of its R&D and manufacturing assets, reflecting the physical scale behind the creation of these high-tech implantable devices.
Market segment balance sheet capitalization - Therapeutic medical equipment
Nevro, a manufacturer of chronic pain treatment systems, is a capital-intensive business. It requires R&D and manufacturing capabilities to create its neurostimulators. The BCap_Seg chart for the medical device sector demonstrates just how "heavy" this innovative industry is.
Book value of all companies included in the broad market index - GURU.Markets
Nevro Corp.'s balance sheet is its technology and manufacturing capabilities for creating a spinal cord neurostimulation system for the treatment of chronic pain. The company's assets include its patents and manufacturing facilities. The chart allows you to assess the material weight of this leading pain management company.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Nevro Corp.
Nevro Corp. produces systems for treating chronic pain. Its balance sheet reflects the value of its patents and manufacturing equipment. Its market capitalization is an assessment of the effectiveness of its technology and its share of the medical device market. The chart shows how investors view its competitive position and innovation.
Market to book capitalization ratio in a market segment - Therapeutic medical equipment
Nevro Corp. has developed and markets a unique spinal cord stimulation system for the treatment of chronic pain, which differentiates itself from competitors' products. Its market valuation on the chart reflects the value of this patented technology and its share of the neuromodulation market.
Market to book capitalization ratio for the market as a whole
Nevro Corp. develops devices for the treatment of chronic pain. The company's value is determined by its patents, clinical data, and market share. This chart shows the premium investors place on innovation and growth potential in the medical device sector compared to the market average.
Debts of the company, segment and market as a whole
NVRO - Company debts Nevro Corp.
Nevro Corp., a manufacturer of neurostimulation systems for chronic pain, uses debt to fund R&D, clinical trials, and its commercial team. This chart shows how the MedTech company is investing in proving the benefits of its unique technology and expanding its application to treat new types of pain.
Market segment debts - Therapeutic medical equipment
Nevro Corp. produces neurostimulation systems for the treatment of chronic pain. Competing in the medical device market requires ongoing investment in R&D and clinical data. This chart shows how the company manages its significant debt to fund its commercial operations and innovation.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Nevro Corp.
Nevro Corp. has developed and produces a spinal cord stimulation system for the treatment of chronic pain. It is a high-tech medical product. This chart shows how the company uses debt capital to fund expensive clinical research, marketing, and competition with major players in the medical device market.
Market segment debt to market segment book capitalization - Therapeutic medical equipment
Nevro Corp. has developed a neurostimulation system for chronic pain treatment that is an alternative to opioids. This is a significant medical innovation. The chart shows the overall debt burden in the medical device sector, which helps assess how Nevro is funding its clinical research and market share.
Debt to book value of all companies in the market
Nevro Corp. produces chronic pain relief systems, a high-tech medical field requiring ongoing investment in R&D and clinical data. This chart shows the overall debt burden in the market. It helps understand how the company manages its debt in the competitive medical device market and funds innovation.
P/E of the company, segment and market as a whole
P/E - Nevro Corp.
Nevro Corp. has developed and markets a spinal cord neurostimulation system for the treatment of chronic pain. This chart shows how the market is evaluating its unique high-frequency stimulation technology. The dynamics reflect its competition with other manufacturers and its ability to demonstrate the clinical benefits of its approach.
P/E of the market segment - Therapeutic medical equipment
This chart shows the average rating for medical device manufacturers where Nevro Corp. operates. It reflects general expectations for medical innovation. Comparisons with these ratings help understand how the market values Nevro's unique spinal cord stimulation technology for chronic pain and whether it believes it can compete with systems from other major players.
P/E of the market as a whole
Nevro is a medical device company that has developed an innovative neurostimulation system for the treatment of chronic pain. Its growth depends on physician adoption of its technology and its competitive advantages. Its business is driven by medical needs, not by the general economic cycles reflected in this chart.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Nevro Corp.
This chart for Nevro Corp., a medical device company that has developed an innovative system for treating chronic pain, shows market expectations for future sales. It reflects forecasts for the growth in the number of patients choosing its spinal cord stimulation technology, which shapes profitability estimates.
%20P%2FE%20Nevro%20Corp.&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-Nevro-Corp.&v=1772585244333 "Chart of the company's future (projected) P/E Nevro Corp.")
Future (projected) P/E of the market segment - Therapeutic medical equipment
Nevro Corp. produces the Senza spinal cord neurostimulation system, which is used to treat chronic pain. The technology's unique feature is its high-frequency stimulation without the sensation of tingling. The chart shows forecasts for the medical device sector. This helps assess the market's confidence in Nevro's technological advantage and its ability to compete with industry giants.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Therapeutic%20medical%20equipment&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Therapeutic-medical-equipment&v=1772585244443 "Future (projected) P/E graph of the market segment - Therapeutic medical equipment")
Future (projected) P/E of the market as a whole
Nevro Corp. produces a spinal cord stimulation system for the treatment of chronic pain. This is a high-tech medical product. Demand for it depends on the acceptance of the technology by doctors and patients. This graph of overall market sentiment influences the valuation of MedTech companies with strong growth but also high competition.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772585244537 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit Nevro Corp.
Nevro Corp. has developed and markets a spinal cord stimulation (SCS) system for the treatment of chronic pain. The company's profits depend on the number of implantations of its devices. This chart shows how the company competes in the high-tech medical device market and how the implementation of its technology impacts its financial results.
Profit of companies in the market segment - Therapeutic medical equipment
Nevro Corp. developed and commercialized the innovative Senza spinal cord stimulation system for the treatment of chronic pain. This chart, which reflects profitability in the therapeutic equipment sector, demonstrates how technology is helping combat pain without opioids. Their high-frequency (HFX) therapy offers patients effective relief, changing the standard of care.
Overall market profit
Nevro Corp. has developed and commercialized an innovative spinal cord stimulation system for the treatment of chronic pain. The company is a leader in this field. Demand for its technology is driven by medical needs. The overall economic situation, as shown in the graph, affects the healthcare system's ability to pay for expensive, high-tech treatments.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Nevro Corp.
Nevro Corp. has developed the innovative Senza spinal cord stimulation system for chronic pain, offering superior pain relief compared to traditional methods. This chart shows analysts' assessments of the technology's adoption rate and its potential to capture share in the multibillion-dollar pain device market.
%20profit%20of%20the%20company%20Nevro%20Corp.&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-Nevro-Corp.&v=1772585244857 "Graph of future (projected) profit of the company Nevro Corp.")
Future (predicted) profit of companies in the market segment - Therapeutic medical equipment
Nevro Corp. is a medical device company that has developed an innovative spinal cord neurostimulation system for the treatment of chronic pain. Growth depends on the adoption of its HF10 technology. This chart for the medical device sector shows the overall growth expectations for the pain management device market, which is an alternative to opioid therapy.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Therapeutic%20medical%20equipment&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Therapeutic-medical-equipment&v=1772585244941 "Graph of future (predicted) profits of companies in a market segment - Therapeutic medical equipment")
Future (predicted) profit of the market as a whole
Nevro Corp. produces a system for treating chronic pain. Demand for such medical devices depends on the availability of procedures and insurance coverage. The overall economic situation, reflected in this graph, impacts healthcare budgets, which may affect the speed of implementation and use of Nevro's technologies.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772585244950 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - Nevro Corp.
Nevro Corp. has developed and commercialized an innovative neurostimulation system for the treatment of chronic pain. The chart shows a high valuation for each dollar of its revenue. This reflects investors' confidence in the superiority of its technology over competitors and its enormous growth potential in the pain-relieving medical device market.
P/S market segment - Therapeutic medical equipment
Nevro Corp. has developed an innovative spinal cord stimulation system for chronic pain treatment that offers an alternative to opioids. The company's revenue is growing as more patients and doctors choose its technology. This chart shows the average valuation in the medical device sector, helping to understand how the market values Nevro's breakthrough solution.
P/S of the market as a whole
Nevro Corp. has developed and markets an innovative spinal cord neurostimulation system for the treatment of chronic pain. The company's technology offers opioid-free pain relief. This chart, showing the average market revenue estimate, helps understand the premium investors are willing to pay for a medical technology that addresses one of the most pressing healthcare challenges.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Nevro Corp.
Nevro Corp. is a medical technology company that has developed an innovative spinal cord stimulation system for the treatment of chronic pain. Its Senza technology is unique. This chart shows how investors view the future adoption of this technology and its ability to compete with traditional treatments and other systems.
%20P%2FS%20Nevro%20Corp.&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-Nevro-Corp.&v=1772585245435 "The graph of the company's future (projected) P/S Nevro Corp.")
Future (projected) P/S of the market segment - Therapeutic medical equipment
Nevro Corp. is a medical device company that developed and commercialized the innovative HFX neurostimulation system for the treatment of chronic pain. This chart shows the average estimated future sales in the medical device sector. It helps understand how highly the market values Nevro's technology for improving patients' quality of life.
%20P%2FS%20market%20segment%20graph%20-%20Therapeutic%20medical%20equipment&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Therapeutic-medical-equipment&v=1772585245526 "Future (projected) P/S market segment graph - Therapeutic medical equipment")
Future (projected) P/S of the market as a whole
Nevro Corp. has developed and commercialized an innovative spinal cord stimulation system for the treatment of chronic pain. This chart illustrates general market expectations. The company's success depends on its technology becoming a new standard in pain treatment, exemplifying how breakthrough medical devices can transform clinical practice and create new markets.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772585245593 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales Nevro Corp.
This chart shows sales for Nevro Corp., a medical technology company that produces the Senza spinal cord stimulation system for the treatment of chronic pain. Revenue is generated from sales of these devices to hospitals for patient implantation. The trend reflects physician adoption of its unique high-frequency therapy.
Sales of companies in the market segment - Therapeutic medical equipment
Nevro Corp. has developed and commercialized an innovative neurostimulation system for the treatment of chronic pain. This graph illustrates the growth of the therapeutic medical device market. Nevro's unique technology offers patients effective pain relief without opioids, making it a key player in the fight against the opioid crisis and a leader in its niche.
Overall market sales
Nevro Corp. produces a neurostimulation system for the treatment of chronic pain. Demand for this expensive medical equipment depends on insurance coverage and hospital budgets. The overall economic situation, reflected in this graph, influences healthcare funding and the availability of high-tech procedures.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Nevro Corp.
Nevro Corp. produces a spinal cord stimulation system for the treatment of chronic pain. The company's future revenue depends on the acceptance of its technology by doctors and patients as an effective alternative to opioids. The chart shows forecasts for the neuromodulation market growth.
%20sales%20of%20the%20company%20Nevro%20Corp.&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-Nevro-Corp.&v=1772585245980 "Schedule of future (projected) sales of the company Nevro Corp.")
Future (projected) sales of companies in the market segment - Therapeutic medical equipment
Nevro Corp. has developed and commercialized an innovative spinal cord neurostimulation system for the treatment of chronic pain. Its HF10 technology offers pain relief without the unpleasant side effects. This graph shows the forecast for the entire therapeutic medical device market, where Nevro is a leader in chronic pain treatment.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Therapeutic%20medical%20equipment&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Therapeutic-medical-equipment&v=1772585246083 "Schedule of future (projected) sales of companies in the market segment - Therapeutic medical equipment")
Future (projected) sales of the market as a whole
Nevro is a medical technology company that has developed and markets a spinal cord stimulation system for the treatment of chronic pain. Demand for their products depends on the number of procedures performed and insurance coverage. This dynamic, reflecting overall healthcare costs, influences the willingness of patients and physicians to choose advanced, but expensive, pain treatments.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772585246211 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality Nevro Corp.
Nevro Corp. manufactures and markets a spinal cord stimulation system for the treatment of chronic pain. The company's profitability depends on successfully promoting its unique technology to doctors and patients. This chart shows how the company competes in the high-tech medical device market, turning pain management innovations into commercial success.
Market segment marginality - Therapeutic medical equipment
Nevro Corp. has developed and commercialized the Senza® spinal cord stimulation system, offering a unique therapy for chronic pain. The company's profitability depends on physician adoption of their patented technology and the competitive advantage it offers. This chart illustrates the commercial success of their innovative approach and the strength of their position in the medical device market.
Market marginality as a whole
Nevro Corp. is a medical device company that has developed an innovative spinal cord stimulation system for the treatment of chronic pain. Their technology provides pain relief without unpleasant side effects. This overall profitability chart is not directly relevant to them. Their growth depends on the acceptance of their technology by doctors and patients as an effective alternative to opioids.
Employees in the company, segment and market as a whole
Number of employees in the company Nevro Corp.
Nevro is a manufacturer of an innovative neurostimulation system for the treatment of chronic pain. A key element of its business model is its large direct sales force, which works with physicians. The growth in this chart is a clear indicator of its commercial efforts to gain market share.
Share of the company's employees Nevro Corp. within the market segment - Therapeutic medical equipment
Nevro Corp. has developed an innovative spinal cord stimulation system for the treatment of chronic pain. This chart reflects the scale of its commercial operations. A significant portion of its team consists of highly qualified clinical specialists who train and support surgeons in implanting this cutting-edge technology.
Number of employees in the market segment - Therapeutic medical equipment
Nevro Corp. is a medical device company that developed and commercialized an innovative spinal cord stimulation system for the treatment of chronic pain. This chart shows employment trends in the neuromodulation sector. The growth in engineers and clinical specialists reflects the successful implementation of this technology, which offers patients an alternative to opioid analgesics.
Number of employees in the market as a whole
Nevro Corp. produces a spinal cord stimulation system for the treatment of chronic pain. Demand for its expensive device depends on patient access to insurance. Stable employment, as seen in this graph, provides more people with good insurance plans that cover such cutting-edge medical technology.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Nevro Corp. (NVRO)
Nevro Corp. manufactures and markets a neurostimulation system (SCS) for the treatment of chronic pain. It is a high-tech medical company. The business model is based on proprietary technology (R&D) and active sales to surgeons (direct S&M). The chart shows how the market values this balance. The high cost per employee reflects both the value of the patent itself and the high margins of the product the team sells.
%20of%20the%20company%20Nevro%20Corp.%20(NVRO)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-Nevro-Corp.-NVRO&v=1772585246765 "Chart of market capitalization per employee (in thousands of dollars) of the company Nevro Corp. (NVRO)")
Market capitalization per employee (in thousands of dollars) in the market segment - Therapeutic medical equipment
Nevro Corp. has developed and markets an innovative spinal cord stimulation system for the treatment of chronic pain. It is a high-tech medical company whose value is based on its unique, patented technology. This chart demonstrates the market's high valuation of its intellectual property and its leading position in its niche.
%20by%20market%20segment%20-%20Therapeutic%20medical%20equipment&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Therapeutic-medical-equipment&v=1772585246873 "Market capitalization per employee (in thousands of dollars) by market segment - Therapeutic medical equipment")
Market capitalization per employee (in thousands of dollars) for the overall market
Nevro Corp. has developed and markets an innovative spinal cord stimulation system for the treatment of chronic pain. The chart shows its valuation in the MedTech sector. The high market capitalization per employee reflects the value of their patented technology, which offers a unique solution for patients who find no relief from other methods.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772585247000 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Nevro Corp. (NVRO)
Nevro is a medical technology company that produces spinal cord stimulation (SCS) systems for the treatment of chronic pain. Their flagship technology is HFX. It's a high-margin business. This chart shows how successful their dedicated sales team is in training doctors and selling these expensive implantable devices to hospitals.
%20Chart%20Nevro%20Corp.%20(NVRO)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-Nevro-Corp.-NVRO&v=1772585247078 "Company Profit Per Employee (in thousands of dollars) Chart Nevro Corp. (NVRO)")
Profit per employee (in thousands of dollars) in the market segment - Therapeutic medical equipment
Nevro Corp. is a medical technology company that produces a spinal cord stimulation (SCS) system for the treatment of chronic pain. It sells high-cost implantable devices. This metric reflects how successfully their sales team promotes this high-margin technology to physicians.
%20in%20the%20market%20segment%20-%20Therapeutic%20medical%20equipment&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Therapeutic-medical-equipment&v=1772585247146 "Chart of profit per employee (in thousands of dollars) in the market segment - Therapeutic medical equipment")
Profit per employee (in thousands of dollars) for the market as a whole
Nevro Corp. (NVRO) is a medical technology company producing a neurostimulation system (Senza) for the treatment of chronic pain. This includes R&D and manufacturing. This chart shows how their patented technology (HFX) is in demand by surgeons and allows them to charge a high price, generating profit per R&D and sales employee.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772585247220 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee Nevro Corp. (NVRO)
Nevro Corp. has developed and markets an innovative neurostimulation system for the treatment of chronic pain. This chart demonstrates the commercial success of its unique technology. The growth in revenue per employee demonstrates the widespread adoption of its system by surgeons and the company's ability to effectively train physicians and sustain sales growth.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-Nevro-Corp.-NVRO&v=1772585247253 "Sales chart per company employee Nevro Corp. (NVRO)")
Sales per employee in the market segment - Therapeutic medical equipment
Nevro Corp. is a major player in the chronic pain treatment market. They produce the Senza spinal cord stimulation (SCS) system, which uses a unique high-frequency therapy (HFX 10 kHz). This chart shows how much revenue each employee (especially their elite sales team) generates from sales of these complex implants, compared to competitors.
Sales per employee for the market as a whole
Nevro (NVRO) manufactures and markets a neurostimulation system (Senza) for the treatment of chronic pain. This is a high-tech medical device. The business requires a large R&D staff to support innovation and, more importantly, an expensive direct sales force to reach surgeons. This chart shows how effectively the company's sales team sells these expensive implants.
Short shares by company, segment and market as a whole
Shares shorted by company Nevro Corp. (NVRO)
Nevro Corp. produces spinal cord stimulation (SCS) systems for the treatment of chronic pain. This chart shows bearish sentiment. Investors are betting that Nevro is losing out to fierce competition from giants like Abbott and Boston Scientific and that its growth in the mature SCS market is slowing.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-Nevro-Corp.-NVRO&v=1772585247483 "Short Shares Chart for the Company Nevro Corp. (NVRO)")
Shares shorted by market segment - Therapeutic medical equipment
Nevro Corp. is an innovator in chronic pain treatment, known for its Senza neurostimulation platform. It is a niche business within the larger medical device sector. This indicator measures the aggregate skepticism of investors (short positions) toward the entire industry. By monitoring it, one can understand how much general concerns or optimism in the sector influence the perception of niche innovators like Nevro.
Shares shorted by the overall market
Nevro (NVRO) produces implants for chronic pain relief. These are often "elective" procedures. When this fear curve rises, investors anticipate a recession. During such periods, patients postpone "non-urgent" but expensive surgeries, which directly impacts demand for NVRO's products.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Nevro Corp. (NVRO)
This chart for Nevro is an indicator of competition in the pain management industry. The company produces a spinal cord stimulation system (Senza). The stock was "overheated" (above 70) at the launch. Fierce competition (Abbott, Boston Sci), patent disputes, and slowing market growth pushed the stock into "oversold" territory (below 30).
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-Nevro-Corp.-NVRO&v=1772585247745 "RSI 14 indicator chart for the company's stock Nevro Corp. (NVRO)")
RSI 14 Market Segment - Therapeutic medical equipment
Nevro (NVRO) is a pain "switch." They produce high-frequency spinal cord stimulation (SCS) systems that help patients manage chronic pain. This chart tracks the pulse of the Therapy Equipment sector. It helps differentiate NVRO technology from the overall "overheated" or "oversold" medtech industry.
RSI 14 for the overall market
For Nevro, a pain management equipment manufacturer, this chart is an indicator of elective surgeries. During periods of euphoria and stability, patients confidently undergo expensive elective surgeries. During periods of market panic and rising unemployment, people, fearing loss of insurance, postpone "non-urgent" surgeries.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast NVRO (Nevro Corp.)
Nevro (NVRO) is a medical device company that produces the HFX iQ system, which uses high-frequency spinal cord stimulation (SCS) to treat chronic pain. This chart shows the average 12-month forecast. It reflects analysts' opinions on Nevro's ability to compete with giants (Abbott, Boston Sci) and grow its share of the SCS device market.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-NVRO-Nevro-Corp.&v=1772585247992 "A chart showing analyst consensus forecasts for the expected stock price. NVRO (Nevro Corp.)")
The difference between the consensus estimate and the actual stock price NVRO (Nevro Corp.)
Nevro (NVRO) is a "pain fighter." The company produces implantable spinal cord stimulators (HFX) for the treatment of chronic pain (back, legs). This chart shows the difference between the market valuation and the consensus forecast. It reveals whether experts believe in their technology and their ability to compete with giants like Abbott and Medtronic.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-NVRO-Nevro-Corp.&v=1772585248005 "A chart showing the difference between the consensus forecast and the actual stock price. NVRO (Nevro Corp.)")
Analyst consensus forecast for stock prices by market segment - Therapeutic medical equipment
Nevro Corp. is a MedTech innovator producing implantable spinal cord stimulators (HFX) for the opioid-free treatment of chronic pain. This chart displays analysts' overall expectations for the *entire* therapeutic medical device sector. It shows whether experts believe the "neuro-stimulation" market will grow.
Analysts' consensus forecast for the overall market share price
Nevro (NVRO) is a drug-free "painkiller." They produce implantable spinal cord stimulators (SCS) that block chronic pain (for example, back pain). This is high-tech medicine. This chart shows the general sentiment of experts. It reflects the extent to which analysts believe the volume of "elective" surgeries in hospitals is stable.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Nevro Corp.
Nevro is a MedTech for chronic pain. Their signature feature is the SCS, an implantable (spinal cord) system (HFX iQ), which (they claim) blocks pain (using high-frequency impulses) better than competitors (Medtronic). This chart is a summary of their implementation history. It reflects their (slowing) sales growth and their uphill battle for market share.
AKIMA Market Segment Index - Therapeutic medical equipment
Nevro Corp (NVRO) is a pain therapy equipment company. Their flagship product (Senza) is a spinal stimulation system that uses unique high-frequency pulses to treat chronic pain. This chart compares their composite index to the sector, showing how their unique technology outperforms the competition.
The AKIM Index for the overall market
Nevro is a MedTech company, a pioneer in high-frequency spinal cord stimulation (10 kHz Therapy) for the treatment of chronic pain. This chart, reflecting the market average, is a backdrop. It helps assess how Nevro, a competitor in the neuromodulation market, compares to overall macroeconomic trends.
